miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer-Role of PTEN

Aleksandra Majewska1,2, Klaudia Brodaczewska1, Aleksandra Filipiak-Duliban1,2

  • 1Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine, 128 Szaserow Street, 04-141 Warsaw, Poland.

Biomolecules
|May 28, 2022
PubMed

Insights

MicroRNA patterns in renal cancer reveal how hypoxia and PTEN loss impact gene expression. Understanding these changes is crucial for developing targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, and their dysregulation is implicated in various pathologies, including cancer.
  • The tumor microenvironment, characterized by features like hypoxia, significantly influences cancer progression and therapeutic responses.
  • PTEN (Phosphatase and Tensin homolog) is a critical tumor suppressor whose alterations are common in cancers.

Purpose of the Study:

  • To investigate the miRNA expression patterns in renal cancer.
  • To elucidate the interplay between hypoxia, PTEN status, and miRNA dysregulation within the tumor microenvironment.
  • To identify potential miRNA-based therapeutic targets for renal cancer.

Main Methods:

  • Utilized CRISPR/Cas9 to create a PTEN knockout in the Renca kidney cancer cell line.
  • Performed global miRNA expression analysis in vitro (normoxic and hypoxic conditions) and in vivo.
  • Validated findings on human renal cancer models with varying PTEN status.

Main Results:

  • Hypoxia universally increased miR-210-3p expression.
  • Hypoxia-induced PTEN decrease correlated with increased miR-221-3p.
  • PTEN loss altered hypoxia-driven miRNA changes, decreasing miR-10b-5p and increasing miR-206-3p.
  • Complete PTEN loss induced miR-155-5p and miR-100-5p.
  • Upregulation of miR-342-3p was observed in PTEN-knockout tumors within the tumor microenvironment.

Conclusions:

  • MiRNA patterns in renal cancer are significantly influenced by both hypoxia and PTEN mutation status.
  • Effective cancer therapy strategies must consider the tumor microenvironment's specific characteristics and genetic alterations.
  • Specific miRNAs (e.g., miR-210-3p, miR-221-3p, miR-10b-5p, miR-206-3p, miR-155-5p, miR-100-5p, miR-342-3p) are potential biomarkers and therapeutic targets in renal cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K